Marietta Investment Partners’s Amgen AMGN Stock Holding History

Marietta Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,420	Closed	-$638K	–	140
2017 Q3	$638K	Buy	+3,420	New	+$606K	0.19%	81

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marietta Investment Partners's AMGN Position: Q4 2017 in Review

Marietta Investment Partners sold out of Amgen (AMGN) in Q4 2017, closing a stake of 3,420 shares — an estimated $638K sold.

Marietta Investment Partners first reported a position in AMGN in Q3 2017 and held it in 1 quarter. The position peaked at $638K in Q3 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

Marietta Investment Partners reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
Marietta Investment Partners sold 3,420 Amgen shares in Q4 2017, an estimated $638K.
Marietta Investment Partners first reported a position in Amgen in Q3 2017 and held it in 1 quarter.
Marietta Investment Partners's Amgen position peaked at $638K in Q3 2017.
1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Marietta Investment Partners's 13F filing for Q4 2017, filed 13 Feb 2018.